Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calmette-Guerin therapy

被引:1
|
作者
Krajewski, Wojciech [1 ]
Zdrojowy, Romuald [1 ]
Kolodziej, Anna [1 ]
机构
[1] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
关键词
Nonmuscle-invasive bladder cancer; Bacillus Calmette-Guerin; Recurrence; Progression; Purified protein derivative skin test;
D O I
10.1016/j.urolonc.2019.01.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:346 / 347
页数:2
相关论文
共 50 条
  • [21] PROGNOSTIC VALUE OF PURIFIED PROTEIN DERIVATIVE SKIN-TEST AND GRANULOMA-FORMATION IN PATIENTS TREATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN
    KELLEY, DR
    HAAFF, EO
    BECICH, M
    LAGE, J
    BAUER, WC
    DRESNER, SM
    CATALONA, WJ
    RATLIFF, TL
    JOURNAL OF UROLOGY, 1986, 135 (02): : 268 - 271
  • [22] The current landscape of salvage therapies for patients with bacillus Calmette-Guerin unresponsive nonmuscle invasive bladder cancer
    Packiam, Vignesh T.
    Richards, Jordan
    Schmautz, Maximilian
    Heidenreich, Axel
    Boorjian, Stephen A.
    CURRENT OPINION IN UROLOGY, 2021, 31 (03) : 178 - 187
  • [23] Utilization of Bacillus Calmette- Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages EDITORIAL COMMENT
    Bandari, Jathin
    Maganty, Avinash
    Davies, Benjamin J.
    UROLOGY, 2019, 124 : 125 - 126
  • [24] Re: Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guerin
    Wood, David P.
    JOURNAL OF UROLOGY, 2013, 189 (06): : 2091 - 2091
  • [25] Effectiveness of the Moreau strain of Bacillus Calmette-Guerin (BCG) for nonmuscle invasive bladder cancer.
    Chade, Daher Cezar
    Machado, Andre
    Waksman, Ricardo
    Garcia, Guilherme
    Esteves, Paulo
    Adonias, Sanarelly
    Botelho, Luis
    Cordeiro, Mauricio
    Murta, Claudio
    Ribeiro-Filho, Leopoldo
    Sarkis, Alvaro
    Bastos, Diogo Assed
    Dzik, Carlos
    Srougi, Miguel
    Nahas, William Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] THE IMPACT OF PURIFIED PROTEIN DERIVATIVE PRIOR TO INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: A CONTROLLED CLINICAL TRIAL
    Zawky, Mohamed
    Abdelhalim, Ahmed
    Abol-Enein, Hassan
    Shokeir, Ahmed
    JOURNAL OF UROLOGY, 2023, 209 : E409 - E409
  • [27] The impact of purified protein derivative prior to intravesical bacillus Calmette-Guerin for the treatment of patients with non-muscle invasive bladder cancer: A controlled clinical trial
    Zawky, M.
    Abdelhalim, A.
    Abol-Enein, H.
    Shokeir, A.
    EUROPEAN UROLOGY, 2023, 83 : S607 - S607
  • [28] INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NONMUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER - PATTERNS OF USE, AND IMPACT ON OUTCOMES
    Azer, S.
    Ranasinghe, W.
    Webb, C.
    Lioufas, P. A.
    Cetti, R.
    Frydenberg, M.
    Bolton, D.
    Appu, S.
    Sengupta, S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 40 - 40
  • [29] Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model EDITORIAL COMMENT
    Kamat, Ashish M.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2203 - 2203
  • [30] Utility of bladder EpiCheck methylation test for the surveillance of bladder cancer patients treated with bacillus Calmette-Guerin
    Mengual, L.
    Ingelmo-Torres, M.
    Carrasco, R.
    Roldan, F. L.
    Garcia, M.
    Alcaraz, A.
    Izquierdo, L.
    Ribal, M. J.
    EUROPEAN UROLOGY, 2022, 81 : S116 - S117